期刊文献+

高血压药巴尼地平的高效环保合成新路线探究

下载PDF
导出
摘要 合成了以碳酸氢铵、间硝苯甲醛和乙酰乙酸甲酯为原料经缩合、部分水解,再与(s)-N-苄基-3-羟基吡咯烷经酯化、分步重结晶、成盐得到盐酸巴尼地平的工艺路线。合成的过程中考察了每步反应的各种影响因素,确定了最佳反应条件,使目标产物的分子合成效率更高,最大限度降低了每步昂贵中间体的消耗与成本,并且产物的光学纯度更易得到保证。其反应条件温和,操作简单且易控制,收率较高。本法操作简单,成本较低,适合于工业化生产。
作者 谢明芳
出处 《科技创业月刊》 2014年第3期185-186,共2页 Journal of Entrepreneurship in Science & Technology
基金 湖北省教育厅科研指导性项目(B类)(项目编号:20135K759)
  • 相关文献

参考文献1

二级参考文献10

  • 1[2]Authors/Task Force Members:2007 Guidelines for the Management of Arterial Hypertension.The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC) J Hypertension,2007,25:1105-1187
  • 2[3]The ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or diuretic:The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT).JAMA,2002,288:2981-2997
  • 3[4]Franz HM,Staessen JA.Amlodipine Better Than Lisinopril?:How One Randomized Clinical Trial Ended Fallacies From Observational Studies.Hypertension,2006,48:359-361
  • 4[5]Nissen SE,Tuzcu EM,Libby P,et al.CAMELOT Investigators.Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure:the CAMELOT study:a randomized controlled trial.JAMA,2004,292:2217-2225
  • 5[6]Dahlof B,Sever PS,Poulter NR,et al.ASCOT Investigators.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendoflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA):A multicenter randomized controlled trial.Lancet,2005,366:895-906
  • 6[7]Pahor M,Psaty BM,Alderman MH,et al.Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.Diabetes Care,2000,23:888-892
  • 7[8]PROGRASS Collaborative Study Group.Randomised trial of perindopril based blood pressure-lowering regimen among 6108individuals with previous stroke or transient ischemic attack.Lancet,2001,358:1033-1041
  • 8[9]Wachtell K,Lehto M,Gerdts E,et al.Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.J Am Coll Cardiol,2005,45:712-719
  • 9[10]Maggioni AP,Latini R,Carson PE,et al.Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trial (Val-HeFT).Am Heart J,2005,149:548-557
  • 10[11]Schmieder R,Kjeldsen SE,Julius S,et al.Reduced incidence of new onset atrial fibrillation with angiotensin Ⅱ receptor blockade:the VALUE-trial.J Hypertens,2006,242:S3 (abstract)

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部